key: cord-0721006-xb8lrum9
authors: Stephen, Madeleine; Alshafai, Laila; Detsky, Allan; Fralick, Michael
title: Cerebral venous sinus thrombosis in a patient with delirium secondary to COVID-19
date: 2022-01-10
journal: CMAJ
DOI: 10.1503/cmaj.211745
sha: 45e0f7e7c15c4ed2f5bb21ca55d44d484b46f0d0
doc_id: 721006
cord_uid: xb8lrum9

nan

A 46-year-old woman was transferred to an internal medicine ward after a 5-week stay in the intensive care unit, where she was treated for severe acute respiratory distress syndrome secondary to COVID-19. She had no past medical history and had not received a SARS-CoV-2 vaccine.

Her predominant symptoms while on the ward included confusion, fear, paranoia and a fluctuating ability to speak. Our in itial diagnosis was delirium secondary to critical illness and prolonged exposure to sedating medications. After a week on the ward, the symptoms persisted, with no improvement. A noncontrast computed tomography (CT) scan of the patient's head identified a small focal high density in the right lateral transverse sinus into the junction of the right sigmoid sinus, which raised concern for an acute dural venous thrombosis ( Figure 1A) . A CT venogram showed extensive thromboses extending into the right jugular bulb and right internal jugular vein ( Figure 1B) . We started the patient on therapeutic anticoagulation with lowmolecular-weight heparin (planned duration 6 months), and her delirium resolved 5 days later. Four months later, she made a full recovery and was speaking normally.

Our case is an important reminder that cerebral venous sinus thrombosis (CVST) is associated with COVID-19 as well as the AstraZeneca ChAdOx1-S SARS-CoV-2 vaccine. 1,2 A report from Singapore estimated a 0.005% incidence of CVST in people positive for SARS-CoV-2. 3 A systematic review found that, among patients with concomitant COVID-19 and CVST, the most common symptom was altered mental status (39%), 75% of patients had CVST identified in the transverse sinus on imaging, and the mortality rate was about 40%. 3 The diagnosis of CVST is often missed because symptoms are nonspecific and often subacute. 3, 4 Guidelines suggest that CVST be considered in patients with focal neurologic deficits with accompanying headache and either seizure or altered mental status. 3, 4 The recommended treatment for CVST is low-molecular-weight heparin for 3-6 months. 5

Madeleine Stephen MD, Laila Alshafai MBBS, Allan Detsky MD PhD, Michael Fralick MD PhD n Cite as: CMAJ 2022 January 10;194:E15-6. doi: 10.1503/cmaj.211745 , showing a subtle focal high density in the right lateral transverse sinus into the junction with the right transverse sinus (arrow) and in the right sigmoid sinus (not shown), raising concern for acute dural venous thrombosis. There is no associated edema or hemorrhage. (B) CT venogram, showing near occlusive thrombosis in the right internal jugular vein (dark grey) just below the level of the skull base (blue arrow). Extensive acute thrombosis extended to the right sigmoid sinus and jugular bulb (not shown). Contrast is seen on the contralateral side (light grey), indicating patency (green arrow).

COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review

EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients

Cerebral venous thrombosis: a comprehensive review

Competing interests: Michael Fralick is a consultant for a start-up company, Proof Diagnostics, that has created a point-of-care testing device for SARS-CoV-2. He also holds grants from the Canadian Institutes of Health Research and the Canadian military for clinical trials to identify treatments for COVID-19, outside the submitted work. No other competing interests were declared. This article has been peer reviewed.The authors have obtained patient consent. Clinical images are chosen because they are particularly intriguing, classic or dramatic. Submissions of clear, appropriately labelled highresolution images must be accompanied by a figure caption. A brief explanation (300 words maximum) of the educational importance of the images with minimal references is required. The patient's written consent for publication must be obtained before submission.